Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of Jan. 17)

This week’s View highlights the use of ICD therapy in ischemic vs. non-ischemic cardiomyopathy; what are the (FDG)-positron emission tomography (PET) and MRI findings, and abnormalities in patients with COVID-19; and a meta-analysis examining oral anticoagulation in AFib.




Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Heart Failure and Cardiomyopathies, Prevention

Keywords: EaglesEyeView, Arrhythmias, Cardiac, Cardiac Resynchronization Therapy, Cardiomyopathies, Death, Sudden, Defibrillators, Implantable, Geriatrics, Heart Failure, Myocardial Ischemia, Primary Prevention, Risk Assessment, Tachycardia, Ventricular, Ventricular Fibrillation, ACC COVID-19 Podcast, Biomarkers, COVID-19, COVID-19 Testing, C-Reactive Protein, Diagnostic Imaging, Fluorodeoxyglucose F18, Gadolinium, Inflammation, Interleukin-6, Interleukin-8, Magnetic Resonance Imaging, Phenotype, Positron-Emission Tomography, Stroke Volume, Ventricular Function, Left, Anticoagulants, Atrial Fibrillation, Dabigatran, Embolism, Hemorrhage, Intracranial Hemorrhages, Renal Insufficiency, Chronic, Rivaroxaban, Secondary Prevention, Vascular Diseases, Warfarin


< Back to Listings